Smart Biomedical

Smart Biomedical is an early-stage Canadian medical device company founded in 2020 in Calgary, Alberta. The company's flagship product is the "Smart Drain," designed to facilitate safer and more efficient chest tube insertion for treating pneumothorax—a potentially life-threatening condition caused by collapsed lungs due to trauma or spontaneously. The innovation stems from direct clinical experience by its physician-founders and aims to improve outcomes over existing alternatives. The company has received multiple innovation awards and participated successfully in the Creative Destruction Lab accelerator program. It has expanded operations with divisions in both Calgary (Western) and Kingston, Ontario (Eastern).